Allocations
Maven Capital Partners (Maven) is making a GBP3million investment in Altra Consultants Limited (Altra) to fund the growth of its Lloyds of London registered insurance brokering subsidiary, Parker Norfolk & Partners Ltd (PNP).
Following its acquisition of PNP, Altra obtained all requisite FCA approvals to enable it to use PNP’s Lloyds brass plate thereby delivering significant advantage to Altra’s service offering, enabling the firm to generate revenues via a mixture of direct sales to corporate entities and wholesale insurance from other insurance brokers.
Altra will initially offer Structured Trade Credit insurance broking services, which is the shareholders’ main area
Intel Capital, Intel Corporation’s global investment organisation, has announced new investments totalling more than USD60 million in 15 technology startups, bringing its year-to-date investing to more than USD566 million.
“The world is undergoing a data explosion,” says Wendell Brooks, Intel senior vice president and president of Intel Capital. “By 2020, every autonomous vehicle on the road will create 4 TB of data per day. A million self-driving cars will create the same amount of data every day as three billion people.
“As Intel transitions to a data company, Intel Capital is actively investing in startups across the technology spectrum
London-based impact investment firm Red Ribbon Asset Management has launched the Red Ribbon Private Equity Fund and the Red Ribbon Real Estate Fund.
The funds will focus on socially responsible investments in emerging and growth markets, and India in particular.
The new Funds, both of which are listed, will restrict investment to ventures whose commercial objectives conform strictly to Mainstream Impact Investment criteria. Red Ribbon Asset Management’s Chief Executive Officer, Suchit Punnose, says: “As a firm, we are choosing to invest in well-governed, profitable businesses operating in mainstream markets that have a positive impact on society and the environment. This
Sheridan Capital Partners has completed a majority recapitalisation of existing portfolio company Smile Doctors. Through the recapitalisation, Linden Capital is joining as lead investor while Sheridan and management are both rolling over equity.
“Working with the entire Smile Doctors team to build the national leader in orthodontics has been a true pleasure,” says Jonathan Lewis, Managing Partner at Sheridan Capital Partners. “Together we have expanded the business from its 12 clinics in Texas and Georgia to over 90 clinics across 11 states. This recapitalisation validates the exceptional growth of the business during our ownership, and our continued investment in the
PNC Bank has closed a USD150 million revolving line of credit for CDI Corp, a portfolio company of AE Industrial Partners. PNC Bank served as administrative agent.
CDI Corp will use the funds, in part, to repay existing debt, partially finance the acquisition by AE Industrial Partners, LLC, and provide for ongoing working capital needs. Products associated with the transaction include treasury management services.
Based in Philadelphia, CDI Corp is a global staffing business that delivers solutions based on highly skilled technical and professional talent. Founded in 1950, the company delivers expertise in engineering and information technology solutions encompassing
Legal practice Osborne Clarke has advised RJD Partners (RJD), the UK Private Equity investor, on the management buyout of Class Tours Limited (Class Tours), a leading provider of language programmes and educational tours to schools in the UK.
This is the fourth investment from RJD’s third buyout fund, following the investment in Barber of Sheffield, and follows RJD’s successful investment track record in the education and leisure sectors.
Based in Hove, Class Tours is a well-respected provider of language programmes to schools with its Château de la Baudonnière courses in Normandy perhaps the most well-known. The business also provides
DataSine has raised EUR1 million in funding from investors including C Entrepreneurs, Sistema_VC and Force Over Mass at the close of the company’s seed round.
DataSine’s proprietary technology analyses transactional and biographical data to determine a customer’s personality, needs, behaviours, and life situation. This enables companies to offer products and services that are directly relevant to their customers and explain them in a way that resonates with each individual.
“DataSine’s technology is unique because it bridges the gap between machine learning, psychology and finance. Put simply – it is the ultimate personalisation engine for banks,” says Igor Volzhanin, Chief
Limerston Capital has acquired Crawford Scientific Holdings Ltd (Crawford), comprising Crawford Scientific Ltd and Hall Analytical Laboratories), from Maven Capital Partners.
Crawford is one of the UK’s leading independent providers of outsourced chromatography consumables and services to the laboratory research and testing sector. This is the third investment of Limerston Capital’s debut fund, Limerston Capital Partners I.
Scotland based Crawford Scientific (founded in 1985) and Manchester based Hall Analytical Laboratories (founded in 1987) provide an array of products and services encompassing consumables distribution with expert advice, training and specialist analytical services to offer the UK’s leading pharmaceutical, research and laboratory
Capagro has closed a second funding round worth EUR66 million following the reopening of the subscription period for its French AgTech-focused venture capital vehicle, Capagro Innovation, back in January.
Established in April 2014 with an initial allocation of EUR37.5 million, which rose to EUR58 million following the first subscription period completed in January 2016, Capagro Innovation set itself the objective of doubling in size through a new investor round.
This goal has now been reached as the fund’s allocation has risen to EUR124 million, higher than the initial objective of EUR120 million. The fund has also welcomed some new
UK private equity firm Maven Capital Partners has exited its investment in Crawford Scientific (Crawford), a supplier of chromatography products and analytical services to the laboratory research and testing sectors, following its sale to Limerston Capital Partners I.
The sale realised a return for Maven clients of 4.7x the initial investment in just over three years, with an IRR of 70 per cent.
Since investing in August 2014, Maven has worked collaboratively with the business to execute a number of strategic initiatives, including the acquisition of Hall Analytical Laboratories which Maven’s clients also funded. Following the acquisition, Crawford critically increased
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
